Search results (193)
« Back to NewsNew study finds semaglutide (or ‘Ozempic/Wegovy’) safe for brain health with possible benefits for cognition and nicotine dependence
17 July 2024
Semaglutide – widely known as Ozempic or Wegovy – does not appear to negatively impact brain health and is associated with lower risk of cognitive problems and less nicotine dependence, according to a new study.
Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies
15 July 2024
General MRC MHU MRC WIMM Research
Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.
RDM launches new metabolism cross-cutting research theme
12 June 2024
On Monday 10 June, more than 50 members of RDM met to kick off the ‘Metabolism in Molecular Medicine’ cross-cutting research theme.
Heart scans could help thousands avoid unnecessary invasive procedure
5 June 2024
Thousands of patients admitted to hospital every year with suspected heart attacks could avoid an unnecessary invasive procedure if they have a routine heart MRI scan first, according to research led by the Radcliffe Department of Medicine.
AI analysis of routine heart scans can predict risk of a developing heart problems ten years in advance, new research finds
30 May 2024
AMIIC CVM General Publication Research
A research team led by scientists at the Radcliffe Department of Medicine, University of Oxford has developed an Artificial Intelligence (AI) technology which can accurately predict the risk of a heart attack, heart failure or cardiac death from routine cardiac CT scans, up to ten years in advance.
University of Oxford research receives £5 million funding boost from British Heart Foundation
24 May 2024
Funding will support world-leading cardiovascular disease research.
Study outlines feasibility of multiple disease risk prediction model for primary care
23 May 2024
A team of researchers, led by the Radcliffe Department of Medicine, has found that a single, integrated health check carried out in a primary care setting can accurately predict risks for diseases across multiple organs.
Early blood glucose control for people with type 2 diabetes is crucial for reducing complications and prolonging life
18 May 2024
Research led by scientists from the Universities of Oxford and Edinburgh has found that early good blood glucose control can minimise the lifetime risk of diabetes-related complications, including heart attacks, kidney failure and vision loss.
Professor Graham Ogg Receives Wellcome Discovery Award with International Team
16 April 2024
Awards General MRC TIDU MRC WIMM Research
Professor Graham Ogg, from the MRC Weatherall Institute of Molecular Medicine has been awarded funding for an international 8-year research programme from global charitable foundation Wellcome.
UK’s first registry to be set up for those at risk of type 1 diabetes
11 March 2024
Researchers from the Oxford BRC and other collaborating organisations have received funding to set up a UK registry for children and adults who are at risk of type 1 diabetes and have tested positive for diabetes autoantibodies.
World Cancer Day 2024: Highlighting cancer research at the MRC WIMM
4 February 2024
Department General MRC MHU MRC WIMM Research
This World Cancer Day, we heard from four Group Leaders at the MRC Weatherall Institute of Molecular Medicine about their work and how their groups are helping in the fight against cancer.
Race to cure type 1 diabetes gets a new boost
7 December 2023
Department General OCDEM Research
RDM group awarded £2.55 million for diabetes research.
AI tool could help thousands avoid fatal heart attacks
14 November 2023
AMIIC CVM Department General Publication Research
An Artificial Intelligence (AI) tool that can predict 10-year risk of deadly heart attacks, could transform treatment for patients who undergo CT scans to investigate chest pain, according to British Heart Foundation (BHF)-funded research presented at the American Heart Association’s Scientific Sessions in Philadelphia.